These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6321539)

  • 1. Dermatitis herpetiformis: effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity.
    Kazmierowski JA; Ross JE; Peizner DS; Wuepper KD
    J Clin Immunol; 1984 Jan; 4(1):55-64. PubMed ID: 6321539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis.
    Stendahl O; Molin L; Dahlgren C
    J Clin Invest; 1978 Jul; 62(1):214-20. PubMed ID: 207742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone suppresses integrin-mediated neutrophil adherence function.
    Booth SA; Moody CE; Dahl MV; Herron MJ; Nelson RD
    J Invest Dermatol; 1992 Feb; 98(2):135-40. PubMed ID: 1732379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-mediated release of histamine from mast cells. Effect of myeloperoxidase and its inhibition by antiinflammatory sulfone compounds.
    Stendahl O; Molin L; Lindroth M
    Int Arch Allergy Appl Immunol; 1983 Mar; 70(3):277-84. PubMed ID: 6186607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of transferrin iron binding capacity by the neutrophil myeloperoxidase system.
    Clark RA; Pearson DW
    J Biol Chem; 1989 Jun; 264(16):9420-7. PubMed ID: 2542309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METHEMOGLOBINEMIA ASSOCIATED WITH THE INGESTION OF DIASONE.
    FISHER I; ORKIN M
    Arch Dermatol; 1965 Sep; 92():327. PubMed ID: 14329241
    [No Abstract]   [Full Text] [Related]  

  • 8. Dapsone and human polymorphonuclear leucocyte chemotaxis in dermatitis herpetiformis.
    Millar BW; Macdonald KJ; Macleod TM; Raffle EJ
    Acta Derm Venereol; 1984; 64(5):433-6. PubMed ID: 6208726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase.
    Kettle AJ; Gedye CA; Winterbourn CC
    Biochem Pharmacol; 1993 May; 45(10):2003-10. PubMed ID: 8390258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Cases of Dermatitis Herpetiformis Successfully Treated with Tetracycline and Niacinamide.
    Wang Y; Yang B; Zhou G; Zhang F
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):273-275. PubMed ID: 30390734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between dapsone dose, serum concentration and disease severity in dermatitis herpetiformis.
    Sanders SW; Zone JJ
    Arzneimittelforschung; 1986; 36(1):146-9. PubMed ID: 3954818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of chemiluminescence in human neutrophils by dapsone.
    Webster GF; Alexander JC; McArthur WP; Leyden JJ
    Br J Dermatol; 1984 Jun; 110(6):657-63. PubMed ID: 6733037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the inhibitory effects of analogues of dapsone on neutrophil function in-vitro.
    Coleman MD; Smith JK; Perris AD; Buck NS; Seydel JK
    J Pharm Pharmacol; 1997 Jan; 49(1):53-7. PubMed ID: 9120771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Sulfoxone (Diasone) sodium for dermatitis herpetiformis" by Cornbleet, December 1951. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis.
    Katz SI
    Arch Dermatol; 1982 Oct; 118(10):805-12. PubMed ID: 6753759
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
    English D; Lukens JN
    J Immunol; 1983 Feb; 130(2):850-6. PubMed ID: 6294178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of tumour cell destruction by PMA-activated human neutrophils.
    Dallegri F; Frumento G; Patrone F
    Immunology; 1983 Feb; 48(2):273-9. PubMed ID: 6295926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by sulfonamides of the candidacidal activity of human neutrophils.
    Lehrer RI
    J Clin Invest; 1971 Dec; 50(12):2498-505. PubMed ID: 4108538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.
    Anderson R; Gatner EM; van Rensburg CE; Grabow G; Imkamp FM; Kok SK; van Rensburg AJ
    Antimicrob Agents Chemother; 1981 Apr; 19(4):495-503. PubMed ID: 6264848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidant membrane injury by the neutrophil myeloperoxidase system. II. Injury by stimulated neutrophils and protection by lipid-soluble antioxidants.
    Sepe SM; Clark RA
    J Immunol; 1985 Mar; 134(3):1896-901. PubMed ID: 2981926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dapsone and gluten-free diet on the immune complexes in the skin of patients with dermatitis herpetiformis [proceedings].
    van der Meer JB; Poen H; van der Putte SC; Nefkens MJ; Baart de la Faille-Kuyper EH
    Br J Dermatol; 1979 Aug; 101(2):232-3. PubMed ID: 486336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.